Sana Biotechnology Inc. (SANA)
NASDAQ: SANA
· Real-Time Price · USD
3.33
-0.10 (-2.92%)
At close: Aug 15, 2025, 3:59 PM
3.36
0.75%
After-hours: Aug 15, 2025, 07:52 PM EDT
Sana Biotechnology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 15.28M | 15.28M | 15.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 161.53M | 161.53M | 161.53M |
Cost of Revenue | 18.2M | 19.24M | 19.34M | 19.24M | 19.68M | 23.64M | 19.89M | 12.35M | 15.04M | 10.99M | 17.21M | 22.8M | 20.24M | 16.44M | 10.22M | 4.64M | n/a | n/a |
Gross Profit | -2.92M | -3.96M | -4.06M | -19.24M | -19.68M | -23.64M | -19.89M | -12.35M | -15.04M | -10.99M | -17.21M | -22.8M | -20.24M | -20.49M | -17.91M | 149.19M | 153.84M | 157.88M |
Operating Income | -258.23M | -212.63M | -272.72M | -312.48M | -252.9M | -319.81M | -293.14M | -284.31M | -368.32M | -324.93M | -272.56M | -302.06M | -299.3M | -207.84M | -356.91M | -358.95M | -327.17M | -433.63M |
Interest Income | 5.8M | 8.43M | 10.47M | 11.54M | 11.82M | 11M | 9.94M | 8.82M | 7.14M | 5.4M | 3.76M | 2.42M | 1.4M | 894K | 676K | 534K | 524K | 473K |
Pretax Income | -252.18M | -208.67M | -266.76M | -305.81M | -244.9M | -308.61M | -283.25M | -275.58M | -361.69M | -320.15M | -269.48M | -299.76M | -297.91M | -206.76M | -355.93M | -358.37M | -326.56M | -433.05M |
Net Income | -252.18M | -208.67M | -266.76M | -305.81M | -244.9M | -308.61M | -283.25M | -275.58M | -361.69M | -320.15M | -269.48M | -299.76M | -297.91M | -206.76M | -355.93M | -358.37M | -326.56M | -433.05M |
Selling & General & Admin | 53.15M | 59.26M | 64.04M | 67.55M | 72.68M | 72.8M | 73.3M | 75.84M | 72.17M | 73.89M | 71.56M | 60.92M | 58.84M | 53.02M | 50.41M | 46.94M | 40.6M | 34.14M |
Research & Development | 150.21M | 156.74M | 212.05M | 248.3M | 183.59M | 247.01M | 219.84M | 208.47M | 296.15M | 251.04M | 201M | 241.14M | 240.46M | 154.82M | 306.5M | 312.02M | 286.56M | 399.49M |
Other Expenses | 1.1M | -4.12M | -3.91M | -4.13M | -3.83M | 210K | -5K | 219K | -190K | 4.39M | 4.29M | 4.57M | 4.69M | 190K | 305K | 53K | 87K | 105K |
Operating Expenses | 204.46M | 212.63M | 272.72M | 291.18M | 231.6M | 298.52M | 271.85M | 284.31M | 368.32M | 324.93M | 272.56M | 302.06M | 299.3M | 207.84M | 356.91M | 358.95M | 327.17M | 433.63M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 207.32M | 212.63M | 272.72M | 298.72M | 239.14M | 306.06M | 279.39M | 284.31M | 368.32M | 324.93M | 272.56M | 302.06M | 299.3M | 207.84M | 356.91M | 358.95M | 327.17M | 433.63M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -637K | -874K | -874K | -1.03M | -525K | -409K | -2.29M | -2.28M | -2.23M |
Shares Outstanding (Basic) | 238.41M | 237.58M | 236.3M | 235.41M | 234.44M | 217.29M | 197.32M | 196.98M | 192.54M | 191.23M | 190.42M | 189.3M | 187.63M | 185.96M | 183.99M | 181.83M | 179.9M | 177.61M |
Shares Outstanding (Diluted) | 238.41M | 237.58M | 236.3M | 235.41M | 234.44M | 217.29M | 197.32M | 200.47M | 192.54M | 191.23M | 190.42M | 189.3M | 187.63M | 185.96M | 183.99M | 181.83M | 190.51M | 182.91M |
EPS (Basic) | -1.06 | -0.88 | -1.16 | -1.4 | -1.14 | -1.52 | -1.46 | -1.43 | -1.89 | -1.69 | -1.43 | -1.61 | -1.62 | -1.13 | -1.98 | -2.03 | -1.96 | -2.73 |
EPS (Diluted) | -1.06 | -0.88 | -1.16 | -1.4 | -1.15 | -1.53 | -1.47 | -1.44 | -1.89 | -1.69 | -1.43 | -1.61 | -1.62 | -1.14 | -1.96 | -2.01 | -1.94 | -2.7 |
EBITDA | -243.04M | -193.54M | -250.29M | -286.26M | -226.24M | -292.61M | -268.58M | -266.82M | -351.31M | -308.57M | -256.94M | -284.5M | -282.87M | -192.61M | -343.04M | -349.46M | -319.04M | -426.72M |
EBIT | -255.03M | -211.52M | -268.36M | -309.91M | -250.57M | -316.56M | -291.21M | -281.04M | -363.98M | -320.59M | -270.15M | -300.44M | -298.58M | -207M | -355.93M | -358.37M | -326.75M | -433.34M |
Depreciation & Amortization | 16.26M | 17.29M | 17.39M | 22.96M | 23.4M | 27.36M | 31.31M | 27.49M | 30.18M | 26.14M | 22.05M | 17.94M | 15.39M | 14.2M | 12.83M | 11.25M | 8.13M | 6.9M |